The First Key Symposium was held in Stockholm, Sweden, 2–5 September 2003. The aim
of the symposium was to integrate clinical and epidemiological perspectives on the topic of …

Alzheimer's disease (AD) is the leading cause of dementia, and because the primary risk
factor for AD is old age, the prevalence of the disease is increasing dramatically with ageing …

Background Frontotemporal dementia is a highly heritable neurodegenerative disorder. In
about a third of patients, the disease is caused by autosomal dominant genetic mutations …

We assessed the geographical distribution of C9orf72 G 4 C 2 expansions in a pan‐ E
uropean frontotemporal lobar degeneration ( FTLD ) cohort (n = 1,205), ascertained by the E …

Mitochondrial dysfunction is an important contributor to human pathology 1, 2, 3, 4 and it is
estimated that mutations of mitochondrial DNA (mtDNA) cause approximately 0.5–1% of all …

It is well-established that subcompartments of endoplasmic reticulum (ER) are in physical
contact with the mitochondria. These lipid raft-like regions of ER are referred to as mitochondria…

Mutations of mitochondrial DNA (mtDNA) cause several well-recognized human genetic
syndromes with deficient oxidative phosphorylation 1, 2, 3, 4 and may also have a role in …

Background Frontotemporal dementia (FTD) is a complex disorder characterised by a broad
range of clinical manifestations, differential pathological signatures, and genetic variability. …

The heterogeneity of neurodegenerative diseases is a key confound to disease understanding
and treatment development, as study cohorts typically include multiple phenotypes on …

We have generated an animal model for mitochondrial myopathy by disrupting the gene for
mitochondrial transcription factor A (Tfam) in skeletal muscle of the mouse. The knockout …